{"acute febrile neutrophilic dermatosis": 89.43, "acute myeloid leukaemia": 18.93, "acute respiratory distress syndrome": 10.63, "acute respiratory failure": 5.07, "agranulocytosis": 9.28, "anaemia": 2.38, "aortitis": 223.24, "bacterial infection": 6.32, "bone marrow failure": 7.89, "bone pain": 12.76, "capillary leak syndrome": 35.08, "clostridium difficile infection": 7.72, "cytopenia": 5.46, "disease progression": 3.14, "drug exposure before pregnancy": 167.04, "drug ineffective for unapproved indication": 7.43, "febrile neutropenia": 25.94, "graft versus host disease": 11.81, "haemophagocytic lymphohistiocytosis": 8.02, "hepatotoxicity": 2.91, "hypokalaemia": 3.58, "hypotension": 2.3, "hypoxia": 3.78, "ill-defined disorder": 3.88, "immune reconstitution inflammatory syndrome": 31.76, "infection": 4.69, "leukocytosis": 13.51, "leukopenia": 4.23, "mucosal inflammation": 10.58, "multiple organ dysfunction syndrome": 6.08, "myelodysplastic syndrome": 11.45, "neoplasm malignant": 4.23, "neuropathy peripheral": 2.26, "neutropenia": 9.1, "neutrophil count decreased": 2.81, "neutrophil count increased": 21.74, "neutrophilia": 31.34, "off label use": 4.23, "pancytopenia": 4.09, "platelet count decreased": 2.06, "pleural effusion": 2.21, "pneumonia": 2.0, "pneumonitis": 3.77, "product use in unapproved indication": 4.52, "rash maculo-papular": 2.07, "respiratory failure": 3.2, "sepsis": 3.8, "septic shock": 3.9, "skin lesion": 3.45, "splenic rupture": 50.25, "staphylococcal bacteraemia": 20.82, "staphylococcal infection": 3.85, "therapeutic product effect incomplete": 2.05, "therapy non-responder": 6.88, "therapy partial responder": 9.57, "thrombocytopenia": 4.43, "treatment failure": 3.43, "white blood cell count decreased": 3.77, "white blood cell count increased": 9.92}